EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

34 hedge funds and large institutions have $73.1M invested in Eiger BioPharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$17.8M
2
+$12.7M
3
+$9.83M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$6.23M
5
PHS
PFM Health Sciences
California
+$4.59M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$17.8M
2
$12.7M
3
$9.83M
4
$6.23M
5
$4.59M
6
$4.38M
7
$3.24M
8
$3.15M
9
$2.06M
10
$1.59M
11
$1.2M
12
$1.03M
13
$846K
14
$480K
15
$415K
16
$403K
17
$372K
18
$307K
19
$294K
20
$290K
21
$256K
22
$245K
23
$182K
24
$181K
25
$174K
1
2